Average Insider

Where insiders trade, we follow

ADARx Pharmaceuticals, Inc. ($ADRX)
Accession: 0000947871-26-000912
Sep 30, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$18.50
Current$19.9430.6% above low, 69.4% below high
52W High$23.21

Filing Information

Accession Number0000947871-26-000912
Form Type4
Filing DateSep 30, 2026
DocumentView SEC Filing
Transactions
9
Total Shares
18,522,534
Total Value
$1,045,772.00
P&L
+17.3% (+$180,857.04)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Chimovits Erez
Director
Common Stock
โ€”Sep 28, 2026Conversion7,127,019โ€”โ€”7,127,019IndirectSee footnotesView Details
Chimovits Erez
Director
Common Stock
โ€”Sep 28, 2026Conversion1,333,975โ€”โ€”8,460,994IndirectSee footnotesView Details
Chimovits Erez
Director
Common Stock
โ€”Sep 28, 2026Conversion513,067โ€”โ€”8,974,061IndirectSee footnotesView Details
Chimovits Erez
Director
Common Stock
โ€”Sep 28, 2026Conversion256,448โ€”โ€”9,230,509IndirectSee footnotesView Details
Chimovits Erez
Director
Common Stock
โ€”Sep 28, 2026Purchase61,516$17.00$1,045,772.009,292,025IndirectSee footnotesView Details
Chimovits Erez
Director
Series A Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion7,127,019$0.00$0.000IndirectSee footnotesView Details
Chimovits Erez
Director
Series B Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion1,333,975$0.00$0.000IndirectSee footnotesView Details
Chimovits Erez
Director
Series B-1 Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion513,067$0.00$0.000IndirectSee footnotesView Details
Chimovits Erez
Director
Series C Preferred Stock
(Common Stock)
DerivativeSep 28, 2026Conversion256,448$0.00$0.000IndirectSee footnotesView Details
Version: v26.10.6